A Phase II Clinical Study of mFOLFOX6 /XELOX as Adjuvant Chemotherapy after Curative Resection of Stage III Colon Cancer: The FACOS Study-Reference-Cited by-同舟云学术

A Phase II Clinical Study of mFOLFOX6 /XELOX as Adjuvant Chemotherapy after Curative Resection of Stage III Colon Cancer: The FACOS Study

Published:2016 Issue:1 Volume:24 Page:17-22
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Ishibashi Keiichiro¹,Kumamoto Kensuke¹,Koda Keiji²,Kato Hiroyuki³,Nishimura Genichi⁴,Yoshimatsu Kazuhiko⁵,Yokomizo Hajime⁵,Ooki Shinji⁶,Tanaka Soichi⁷,Asano Michio⁷,Yokoyama Masaru⁸,Kawada Tomoyuki⁹,Ishida Hideyuki¹

Affiliation:

1. Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University

2. Department of Surgery, Teikyo University Chiba Medical Center

3. Department of Surgery, Sakura Medical Center, School of Medicine, Faculty of Medicine, Toho University

4. Department of Surgery, Japanese Red Cross Kanazawa Hospital

5. Department of Surgery, Tokyo Women's Medical University, Medical Center East

6. Department of Organ Regulatory Surgery, Fukushima Medical University

7. Department of Surgery, Matsuda Hospital

8. Department of Surgery, Higashimatsuyama Medical Association Hospital

9. Department of Hygiene and Public Health, Nippon Medical School

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/24/1/24_17_22/_pdf

Reference22 articles.

1. 1) Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J, Twito DI, Morton RF, Tschetter LK, Barlow JF (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol 7:1447-56.

2. 2) Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-8. DOI: 10.1056/NEJM199002083220602

3. 3) Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol 11:1879-87.

4. 4) International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345:939-44. DOI: 10.1016/S0140-6736(95)90696-7

5. 5) Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 106:899-906.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The updated five-year overall survival and long-term oxaliplatin-related neurotoxicity assessment of the FACOS study;Surgery Today;2021-02-14

2. Safety of mFOLFOX6/XELOX as adjuvant chemotherapy after curative resection of stage III colon cancer: phase II clinical study (The FACOS study);International Journal of Colorectal Disease;2018-02-27